YWHAE was upregulated in breast cancer (Yang et al., 2019), high-grade endometrial stromal sarcoma (Hemming et al., 2017), gastric cancer (Leal et al., 2016), and colorectal cancer (Bjeije et al., 2019) and associated with poor outcomes. Here, YWHAE is linked to gastric cancer.